ARTICLE | Emerging Company Profile
Arteaus: Meeting of minds
Atlas Ventures' Arteaus developing Lilly's CGRP antibody to prevent migraine
April 9, 2012 7:00 AM UTC
Arteaus Therapeutics LLC, the first company to come out of Atlas Venture Development Corp., is going after what could potentially be the first new target to prevent migraine in decades.
Arteaus was formed by two entities set up to do the same thing: develop therapeutics on minimal funding. Eli Lilly and Co.'s Chorus unit and Atlas Venture's AVDC initiative...